Show simple item record

dc.contributor.authorOzden, Ferhat
dc.contributor.authorOnal, Bülent
dc.contributor.authorAki, Hilal
dc.contributor.authorDurak, Haydar
dc.contributor.authorSaygin, Caner
dc.contributor.authorUzunaslan, Didem
dc.date.accessioned2021-03-04T13:12:46Z
dc.date.available2021-03-04T13:12:46Z
dc.date.issued2013
dc.identifier.citationOzden F., Saygin C., Uzunaslan D., Onal B., Durak H., Aki H., "Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, cilt.139, sa.8, ss.1373-1382, 2013
dc.identifier.issn0171-5216
dc.identifier.otherav_7b328343-952c-48e7-b66a-66edf0fa1865
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/84368
dc.identifier.urihttps://doi.org/10.1007/s00432-013-1453-x
dc.description.abstractMatrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) participate in tumorigenesis, and their association with disease outcome is highly controversial. The present study investigates the influence of MMP-1, MMP-9 and TIMP-2 on different clinicopathologic variables and disease-free survival (DFS) of patients with prostate carcinoma.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleExpression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival
dc.typeMakale
dc.relation.journalJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume139
dc.identifier.issue8
dc.identifier.startpage1373
dc.identifier.endpage1382
dc.contributor.firstauthorID59184


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record